The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level


Asa S., AKSOY S. Y. , Vatankulu B. , Aliyev A., Uslu L., OZHAN M. , ...Daha Fazla

ANNALS OF NUCLEAR MEDICINE, cilt.28, ss.970-979, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 28 Konu: 10
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s12149-014-0897-7
  • Dergi Adı: ANNALS OF NUCLEAR MEDICINE
  • Sayfa Sayıları: ss.970-979

Özet

In the follow-up of differentiated thyroid cancer (DTC) after a successful total-near total thyroidectomy and I-131 ablation therapy, anti-thyroglobulin antibodies (anti-Tg) may be persistently or progressively increased in the patients with an undetectable serum thyroglobulin (Tg) level. In these cases, further investigation was performed to search for recurrence/metastases. The aim of our study was clarifying the role of FDG-PET/CT in detecting recurrence/metastasis in patients with DTC with negative serum Tg and elevated anti-Tg level.